The global Rare Disease Genetic Testing Market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.5 billion in 2026 to USD 3.9 billion by 2033, registering a CAGR of 14.9% from 2026 to 2033. North America accounted for the largest revenue share of 46.7% in 2025, supported by advanced genomic research, widespread adoption of next-generation sequencing (NGS),...

Building a bioinformatics pipeline for research is one thing. Building one that reliably processes thousands of patient samples in a clinical environment is something entirely different. Many genomics teams begin with research-grade workflows that perform well during early development but struggle once they move into production. As sample volumes increase, pipelines become slower, integrations...

North America holds a dominant position in the Genomics Market due to its advanced healthcare infrastructure, strong research ecosystem, and early adoption of next-generation sequencing (NGS) technologies. The region is home to leading biotechnology and pharmaceutical companies, world-class academic institutions, and large-scale genomic research initiatives. The increasing focus on precision...

Artificial intelligence has moved far beyond experimentation. Today, organizations across industries are embedding AI directly into their core workflows to improve decision-making, automate operations, and unlock new forms of value from data. However, building production-ready AI systems requires more than simply experimenting with models. Successful AI adoption demands scalable infrastructure,...

Genomics is transforming healthcare, enabling researchers and clinicians to understand diseases at a molecular level and deliver personalized treatments. But as sequencing technologies generate larger volumes of data, many organizations face a growing challenge: turning genomic data into reliable, clinically actionable insights. To overcome these challenges, life sciences companies are...